Evidence map›Paper›PMID 38687216›Full record

ArticleRadiology2024

BI-RADS Category Assignments by GPT-3.5, GPT-4, and Google Bard: A Multilanguage Study.

Andrea Cozzi, Katja Pinker, Andri Hidber, Tianyu Zhang, Luca Bonomo, Roberto Lo Gullo, Blake Christianson, Marco Curti, Stefania Rizzo, Filippo Del Grande and 2 more

Abstract read
In one paragraph

Article in Radiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. [Research progress of large language models in tumor diagnosis: applications in textual reports and medical imaging].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Andrea Cozzi *From the Imaging Institute of Southern Switzerland (IIMSI), Ente Ospedaliero Cantonale, Via Tesserete 46, 6900 Lugano, Switzerland (A.C., L.B., M.C., S.R., F.D.G., S.S.); Breast Imaging Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY (K.P., R.L.G., B.C.); Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland (A.H., S.R., F.D.G., S.S.); Department of Radiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (T.Z., R.M.M.); Department of Diagnostic Imaging, Radboud University Medical Center, Nijmegen, the Netherlands (T.Z., R.M.M.); and GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands (T.Z.).ORCID 0000-0003-4922-7065
Katja Pinker *From the Imaging Institute of Southern Switzerland (IIMSI), Ente Ospedaliero Cantonale, Via Tesserete 46, 6900 Lugano, Switzerland (A.C., L.B., M.C., S.R., F.D.G., S.S.); Breast Imaging Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY (K.P., R.L.G., B.C.); Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland (A.H., S.R., F.D.G., S.S.); Department of Radiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (T.Z., R.M.M.); Department of Diagnostic Imaging, Radboud University Medical Center, Nijmegen, the Netherlands (T.Z., R.M.M.); and GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands (T.Z.).ORCID 0000-0002-2722-7331
Andri HidberFrom the Imaging Institute of Southern Switzerland (IIMSI), Ente Ospedaliero Cantonale, Via Tesserete 46, 6900 Lugano, Switzerland (A.C., L.B., M.C., S.R., F.D.G., S.S.); Breast Imaging Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY (K.P., R.L.G., B.C.); Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland (A.H., S.R., F.D.G., S.S.); Department of Radiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (T.Z., R.M.M.); Department of Diagnostic Imaging, Radboud University Medical Center, Nijmegen, the Netherlands (T.Z., R.M.M.); and GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands (T.Z.).ORCID 0009-0005-6239-3377
Tianyu ZhangFrom the Imaging Institute of Southern Switzerland (IIMSI), Ente Ospedaliero Cantonale, Via Tesserete 46, 6900 Lugano, Switzerland (A.C., L.B., M.C., S.R., F.D.G., S.S.); Breast Imaging Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY (K.P., R.L.G., B.C.); Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland (A.H., S.R., F.D.G., S.S.); Department of Radiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (T.Z., R.M.M.); Department of Diagnostic Imaging, Radboud University Medical Center, Nijmegen, the Netherlands (T.Z., R.M.M.); and GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands (T.Z.).ORCID 0000-0001-9891-6874
Luca BonomoFrom the Imaging Institute of Southern Switzerland (IIMSI), Ente Ospedaliero Cantonale, Via Tesserete 46, 6900 Lugano, Switzerland (A.C., L.B., M.C., S.R., F.D.G., S.S.); Breast Imaging Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY (K.P., R.L.G., B.C.); Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland (A.H., S.R., F.D.G., S.S.); Department of Radiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (T.Z., R.M.M.); Department of Diagnostic Imaging, Radboud University Medical Center, Nijmegen, the Netherlands (T.Z., R.M.M.); and GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands (T.Z.).ORCID 0000-0002-6978-9033
Roberto Lo GulloFrom the Imaging Institute of Southern Switzerland (IIMSI), Ente Ospedaliero Cantonale, Via Tesserete 46, 6900 Lugano, Switzerland (A.C., L.B., M.C., S.R., F.D.G., S.S.); Breast Imaging Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY (K.P., R.L.G., B.C.); Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland (A.H., S.R., F.D.G., S.S.); Department of Radiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (T.Z., R.M.M.); Department of Diagnostic Imaging, Radboud University Medical Center, Nijmegen, the Netherlands (T.Z., R.M.M.); and GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands (T.Z.).
Blake ChristiansonFrom the Imaging Institute of Southern Switzerland (IIMSI), Ente Ospedaliero Cantonale, Via Tesserete 46, 6900 Lugano, Switzerland (A.C., L.B., M.C., S.R., F.D.G., S.S.); Breast Imaging Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY (K.P., R.L.G., B.C.); Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland (A.H., S.R., F.D.G., S.S.); Department of Radiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (T.Z., R.M.M.); Department of Diagnostic Imaging, Radboud University Medical Center, Nijmegen, the Netherlands (T.Z., R.M.M.); and GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands (T.Z.).ORCID 0009-0004-9327-2626
Marco CurtiFrom the Imaging Institute of Southern Switzerland (IIMSI), Ente Ospedaliero Cantonale, Via Tesserete 46, 6900 Lugano, Switzerland (A.C., L.B., M.C., S.R., F.D.G., S.S.); Breast Imaging Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY (K.P., R.L.G., B.C.); Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland (A.H., S.R., F.D.G., S.S.); Department of Radiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (T.Z., R.M.M.); Department of Diagnostic Imaging, Radboud University Medical Center, Nijmegen, the Netherlands (T.Z., R.M.M.); and GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands (T.Z.).
Stefania RizzoFrom the Imaging Institute of Southern Switzerland (IIMSI), Ente Ospedaliero Cantonale, Via Tesserete 46, 6900 Lugano, Switzerland (A.C., L.B., M.C., S.R., F.D.G., S.S.); Breast Imaging Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY (K.P., R.L.G., B.C.); Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland (A.H., S.R., F.D.G., S.S.); Department of Radiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (T.Z., R.M.M.); Department of Diagnostic Imaging, Radboud University Medical Center, Nijmegen, the Netherlands (T.Z., R.M.M.); and GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands (T.Z.).ORCID 0000-0002-5151-0866
Filippo Del GrandeFrom the Imaging Institute of Southern Switzerland (IIMSI), Ente Ospedaliero Cantonale, Via Tesserete 46, 6900 Lugano, Switzerland (A.C., L.B., M.C., S.R., F.D.G., S.S.); Breast Imaging Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY (K.P., R.L.G., B.C.); Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland (A.H., S.R., F.D.G., S.S.); Department of Radiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (T.Z., R.M.M.); Department of Diagnostic Imaging, Radboud University Medical Center, Nijmegen, the Netherlands (T.Z., R.M.M.); and GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands (T.Z.).
Ritse M Mann *From the Imaging Institute of Southern Switzerland (IIMSI), Ente Ospedaliero Cantonale, Via Tesserete 46, 6900 Lugano, Switzerland (A.C., L.B., M.C., S.R., F.D.G., S.S.); Breast Imaging Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY (K.P., R.L.G., B.C.); Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland (A.H., S.R., F.D.G., S.S.); Department of Radiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (T.Z., R.M.M.); Department of Diagnostic Imaging, Radboud University Medical Center, Nijmegen, the Netherlands (T.Z., R.M.M.); and GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands (T.Z.).ORCID 0000-0001-8111-1930
Simone Schiaffino *From the Imaging Institute of Southern Switzerland (IIMSI), Ente Ospedaliero Cantonale, Via Tesserete 46, 6900 Lugano, Switzerland (A.C., L.B., M.C., S.R., F.D.G., S.S.); Breast Imaging Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY (K.P., R.L.G., B.C.); Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland (A.H., S.R., F.D.G., S.S.); Department of Radiology, Netherlands Cancer Institute, Amsterdam, the Netherlands (T.Z., R.M.M.); Department of Diagnostic Imaging, Radboud University Medical Center, Nijmegen, the Netherlands (T.Z., R.M.M.); and GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands (T.Z.).

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Background The performance of publicly available large language models (LLMs) remains unclear for complex clinical tasks. Purpose To evaluate the agreement between human readers and LLMs for Breast Imaging Reporting and Data System (BI-RADS) categories assigned based on breast imaging reports written in three languages and to assess the impact of discordant category assignments on clinical management. Materials and Methods This retrospective study included reports for women who underwent MRI, mammography, and/or US for breast cancer screening or diagnostic purposes at three referral centers. Reports with findings categorized as BI-RADS 1-5 and written in Italian, English, or Dutch were collected between January 2000 and October 2023. Board-certified breast radiologists and the LLMs GPT-3.5 and GPT-4 (OpenAI) and Bard, now called Gemini (Google), assigned BI-RADS categories using only the findings described by the original radiologists. Agreement between human readers and LLMs for BI-RADS categories was assessed using the Gwet agreement coefficient (AC1 value). Frequencies were calculated for changes in BI-RADS category assignments that would affect clinical management (ie, BI-RADS 0 vs BI-RADS 1 or 2 vs BI-RADS 3 vs BI-RADS 4 or 5) and compared using the McNemar test. Results Across 2400 reports, agreement between the original and reviewing radiologists was almost perfect (AC1 = 0.91), while agreement between the original radiologists and GPT-4, GPT-3.5, and Bard was moderate (AC1 = 0.52, 0.48, and 0.42, respectively). Across human readers and LLMs, differences were observed in the frequency of BI-RADS category upgrades or downgrades that would result in changed clinical management (118 of 2400 [4.9%] for human readers, 611 of 2400 [25.5%] for Bard, 573 of 2400 [23.9%] for GPT-3.5, and 435 of 2400 [18.1%] for GPT-4;

Indexed as

Breast NeoplasmsAdultAgedBreastFemaleHumansLanguageMagnetic Resonance ImagingMammographyMiddle AgedRadiology Information SystemsRetrospective StudiesUltrasonography, Mammary

Identifiers

PMID38687216
PMCPMC11070611

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.